Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation

Heart Rhythm

Volumn 12, Issue 7, 2015, Pages 1565-1573

  Healy, Christopher A ^a   Carrillo, Roger G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac implantable electronic device; Device extraction; Device infection; Implantable cardioverter defibrillator; Wearable cardioverter defibrillator

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; DEVICE INFECTION; DEVICE REMOVAL; HEALTH CARE COST; HEALTH CARE FACILITY; HEART PROTECTION; HOME; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; OUTPATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; SKILLED NURSING FACILITY; SUDDEN CARDIAC DEATH; WEARABLE CARDIOVERTER DEFIBRILLATOR; ADVERSE EFFECTS; COST BENEFIT ANALYSIS; DEATH, SUDDEN, CARDIAC; DECISION SUPPORT SYSTEM; ECONOMICS; MORTALITY; PATIENT CARE; PROCEDURES; PROSTHESIS-RELATED INFECTIONS; RISK ASSESSMENT; TREATMENT OUTCOME; UNITED STATES;

COST-BENEFIT ANALYSIS; DEATH, SUDDEN, CARDIAC; DECISION SUPPORT TECHNIQUES; DEFIBRILLATORS; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT CARE MANAGEMENT; PATIENT DISCHARGE; PROSTHESIS-RELATED INFECTIONS; RISK ASSESSMENT; UNITED STATES;

EID: 84937413050     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2015.03.061     Document Type: Article

References (33)

1. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, and et al. 2012 ACCF/AHA/HRS Focused Update Incorporated nto the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 61 2013 e6 e75
2. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 337 1997 1576 1583
3. K. Kuck, R. Cappato, J. Siebels, and R. Ruppel Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH) Circulation 102 2000 748 754
4. A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, D.S. Cannom, J.P. Daubert, S.L. Higgins, M.W. Brown, and M.L. Andrews Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
5. E. Athan, V.H. Chu, P. Tattevin, and et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices JAMA 16 2012 1727 1735
6. A.J. Greenspon, J.D. Patel, E. Lau, J.A. Ochoa, D.R. Frisch, R.T. Ho, B.B. Pavri, and S.M. Kurtz 16-year trends in infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008 J Am Coll Cardiol 10 2011 1001 1006
7. L.M. Baddour, A.E. Epstein, C.C. Erickson, and et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association Circulation 3 2010 458 477
8. A. Feldman, H. Klein, P. Tchou, and et al. Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of WEARIT/BIROAD Pacing Clin Electrophysiol 27 2004 4 9
9. B.L. Wilkoff, C.J. Love, C.L. Byrd, and et al. Transvenous lead extraction: Heart Rhythm Society Expert Consensus on Facilities, Training, Indications, and Patient Management Heart Rhythm 6 2009 1085 1104
10. M.C. Weinstein, J.E. Siegel, M.R. Gold, M.S. Kamlet, and L.B. Russell Recommendations of the Panel on Cost-effectiveness in Health and Medicine JAMA 276 1996 1253 1258
11. P. Cram, S. Vijan, D. Katz, and A.M. Fendrick Cost-effectiveness of in-home automated external defibrillators for individuals at increased risk of sudden cardiac death J Gen Intern Med 20 2005 251 258
12. M.K. Chung, S.J. Szymkiewicz, M. Shao, E. Zishiri, M.J. Niebauer, B.D. Lindsay, and P.J. Tchou Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival J Am Coll Cardiol. 56 2010 194 203
13. T.G.J. Tanawuttiwat, A. Salow, J.M. Glad, S. Szymkiewicz, H.E. Saltzman, S.P. Kutalek, and R.G. Carrillo Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator PACE 37 2014 562 568
14. A.S. Go, D. Mozaffarian, V.L. Roger, and et al. Heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
15. G. Nichol, T. Valenzuela, D. Roe, L. Clark, E. Huszti, and G.A. Wells Cost effectiveness of defibrillation by targeted responders in public settings Circulation 108 2003 697 703
16. G.H. Bardy, K.L. Lee, D.B. Mark, and et al. Home use of automated external defibrillators for sudden cardiac arrest New Engl J Med 358 2008 1793 1804
17. S.J. Connolly, A.P. Hallstrom, R. Cappato, E.B. Schron, K.H. Kuck, D.P. Zipes, H.L. Greene, S. Boczor, M. Domanski, D. Follmann, M. Gent, and R.S. Roberts Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study Eur Heart J 21 2000 2071 2078
18. M.T. Cudnik, C. Sasson, T.D. Rea, M.R. Sayre, J. Zhang, B.J. Bobrow, D.W. Spaite, B. McNally, K. Denninghoff, and U. Stolz Increasing hospital volume is not associated with improved survival in out of hospital cardiac arrest of cardiac etiology Resuscitation 83 2012 862 868
19. C. Sasson, M.A. Rogers, J. Dahl, and A.L. Kellermann Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis Circ Cardiovasc Qaul Outcomes 3 2010 63 81
20. M.L. Weisfeldt, C.M. Sitlani, J.P. Ornato, and et al. Survival after application of automatic external defibrillators before arrival of the emergency medical system: evaluation in the resuscitation outcomes consortium population of 21 million J Am Coll Cardiol 55 2010 1713 1720
21. V.M. Nadkarni, G.L. Larkin, M.A. Peberdy, S.M. Carey, W. Kaye, M.E. Mancini, G. Nichol, T. Lane-Truitt, J. Potts, J.P. Ornato, and R.A. Berg National Registry of Cardiopulmonary Resuscitation Investigators. First documented rhythm and clinical outcome from in-hospital cardiac arrest among children and adults JAMA 295 2006 50 57
22. K. Nanthakumar, A.E. Epstein, G.N. Kay, V.J. Plumb, and D.S. Lee Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials J Am Coll Cardiol 44 2004 2166 2172
23. G.D. Sanders, M.A. Hlatky, and D.K. Owens Cost-effectiveness of implantable cardioverter-defibrillators New Engl J Med 353 2005 1471 1480
24. Bureau of Labor Statistics Consumer Expenditure Survey. (2014, September 12). Availabe at: http://www.bls.gov/cex/#products
25. T. Morimoto, and T. Fukui Utilities measured by rating scale, time trade-off, and standard gamble: review and reference for health care professionals J Epidemiol 12 2002 160 178
26. J. Tsevat, L. Goldman, J.R. Soukup, G.A. Lamas, K.F. Connors, C.C. Chapin, and T.H. Lee Stability of time-tradeoff utilities in survivors of myocardial infarction Med Decis Making 13 1993 161 165
27. D.G. Fryback, E.J. Dasbach, R. Klein, B.E. Klein, N. Dorn, K. Peterson, and P.A. Martin The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors Med Decis Making 13 1993 89 102
28. T. Shiroiwa, Y.K. Sung, T. Fukuda, H.C. Lang, S.C. Bae, and K. Tsutani International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ 19 2010 422 437
29. A. Auricchio, H. Klein, C.J. Geller, S. Reek, M.S. Heilman, and S.J. Szymkiewicz Clinical efficacy of the wearable cardioverter-defibrillator in acutely terminating episodes of ventricular fibrillation Am J Cardiol 81 1998 1253 1256
30. S. Reek, J.C. Geller, U. Meltendorf, A. Wollbrueck, S.J. Szymkiewicz, and H.U. Klein Clinical efficacy of a wearable defibrillator in acutely terminating episodes of ventricular fibrillation using biphasic shocks Pacing Clin Electrophysiol 26 2003 2016 2022
31. H.U. Klein, U. Meltendorf, S. Reek, J. Smid, S. Kuss, I. Cygankiewicz, C. Jons, S. Szymkiewicz, F. Buhtz, A. Wollbrueck, W. Zareba, and A.J. Moss Bridging a temporary high risk of sudden arrhythmic death: experience with the wearable cardioverter defibrillator (WCD) Pacing Clin Electrophysiol 33 2010 353 367
32. D.J. Cohen, and W.S. Weintraub The limits of cost-effectiveness analysis Circ Cardiovasc Qual Outcomes 2 2009 55 58
33. J.E. Siegel, M.C. Weinstein, L.B. Russell, and M.R. Gold Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine JAMA 276 1996 1339 1341